蚌埠 [切换城市] 蚌埠招聘蚌埠生物/制药/医疗器械招聘蚌埠生物工程/生物制药招聘

Director of in vitro

桑迪亚医药技术(上海)有限责任公司

  • 公司性质:外资(欧美)
  • 公司行业:制药/生物工程

职位信息

  • 发布日期:2017-03-28
  • 工作地点:上海
  • 招聘人数:1人
  • 学历要求:专业培训
  • 职位月薪:20-25万/年
  • 职位类别:生物工程/生物制药  

职位描述

职位描述:
? Responsibility:
1. This individual should have deep understanding of pharmacology, biochemistry or biotechnology and a track record of automated high-throughput screening.
2. Take responsibilities in developing biochemical and cellular assays and providing in vitro screening support. The related activities include, but not limit, designing, validating, executing and troubleshooting experiments, coordinating and leading research project.
3. SKills in communication, scientific problem solving, experimental design, execution and study report writing are essential.
4. Provide the technical training of the new employee and experienced employee in the team. Daily people management of the team. Help to solve any issues or conflict among team members.

? Requirement:
1. Education: PhD degree in pharmacology or biochemistry, at least 8 years of relevant working experience. Master degree is acceptable only when extensive closely related to the experiences are demonstrated.
2. Experience: working experience in high-throughput screening;
3. Technical requirement:
1) An ability and hands-on experience in developing, validating and executing plate-based and biochemical assays, both kinetic and binding.
2) An ability to integrate appropriate automated devices to improve assay throughput and robustness
3) An ability to independently generate precise, reliable data and skillfully analyze and interpret it
4) Others: Good written and oral communication skill in both English and Chinese.

职能类别: 生物工程/生物制药

举报 分享

公司介绍

关于保诺-桑迪亚

保诺-桑迪亚,安宏资本旗下投资企业之一,是业内领先的合同研究、工艺开发和生产公司 (CRDMO),专业为生物制药客户提供全面整合服务,支持药物发现、开发和生产(包括原料药和成品药)。作为全球第三大 CRDMO 公司,保诺-桑迪亚的 10 大办事处遍布全球,旗下拥有 2000 多名员工,在中国和美国开展主要业务。

保诺-桑迪亚在大小分子发现、开发和放大方面拥有核心专业知识,支持 IND 申报,拥有独特的专利技术平台(例如不溶性化合物生物利用度增强平台)。公司在中国和美国均设有研发中心和生产基地。保诺-桑迪亚采用“一站式”运营模式,有效帮助生物制药客户加快发现进程并降低开发风险,从而创造更高价值的药物。

保诺-桑迪亚由安宏资本领投,Bridgewest Business Group 为共同投资者。

联系方式

  • Email:xhsun@sundia.com